Meet the developers behind the Pfizer building conversion
New York City turned its eyes towards the former Pfizer building in Midtown East Tuesday morning, but not for the reason the developers would’ve hoped. Reports emerged before 8 a.m. of debris falling from the construction site at 235 East 42nd Street, arguably the country’s most notable office-to-residential conversion post-pandemic to unfold. As of midday, concerns about the safety of the building remain as columns within the building buckle, forcing evacuations and street closures in and around the property. It’s not the first notable incident at the project, which commanded real estate’s attention long before pedestrians were forced to steer […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Weekend Recap: The Battle for Unique Inventory

Salvation or false hope? Article XI lures landlords

Inside rising townhouse prices across New York
City

NYC’s top deals: Bowery Grand Hotel sells for $8M

Two years later, Brandon Miller fallout ripples through real
estate

NY Dirt: Three takeaways from the Pacific Park MOU

Rabsky co-founders Simon Dushinsky and Isaac Rabinowitz
split. Sort of.

We Buy Houses Salisbury, NC: Top 5 Companies

We Buy Houses Muskogee, OK: Top 5 Companies

We Buy Houses Owasso: Top 5 Companies


